231
Views
14
CrossRef citations to date
0
Altmetric
Research Articles

A 6-month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Middle Eastern and North African men with erectile dysfunction

, , , , , , & show all
Pages 707-717 | Accepted 18 Mar 2013, Published online: 17 Apr 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Irwin Goldstein, Tarek Hassan, Kelly Zou, Victoria Divino, Mitch DeKoven, Joseph Imperato, Vamshi Ruthwik Anupindi & Jim Li. (2023) Health-Care Resource Utilization and Treatment Patterns in Men with Erectile Dysfunction and Benign Prostatic Hyperplasia-Associated Lower Urinary Tract Symptoms in the United States: A Retrospective Database Study. Patient Preference and Adherence 17, pages 2187-2200.
Read now
Eusebio Rubio-Aurioles, Amr El-Meliegy, Samer Abdulwahed, Carsten Henneges, Sebastian Sorsaburu & Sirel Gurbuz. (2015) Decision tree analyses of key patient characteristics in Middle Eastern/North African and Latin American men treated with long-acting and short-acting PDE5 inhibitors for erectile dysfunction. Current Medical Research and Opinion 31:2, pages 367-378.
Read now

Articles from other publishers (12)

Taymour Mostafa, Moheiddin Alghobary, Noha S Hanafy & Ahmed Abosief. (2023) Oral phosphodiesterase type 5 inhibitors and male reproductive potential: an overview. Sexual Medicine Reviews 11:3, pages 240-252.
Crossref
Ibrahim A Abdel-Hamid, Mohamed Abo-Aly & Taymour Mostafa. (2023) Phosphodiesterase type 5 inhibitors and premature ejaculation: an overview of systematic reviews/meta-analyses using the AMSTAR 2, ROBIS, and GRADE tools. Sexual Medicine Reviews 11:1, pages 23-51.
Crossref
Ahmed S. Zaghloul, Abdelrahman M. El‐Nashaar, Shady Z. Said, Ihab A. Osman & Taymour Mostafa. (2022) Assessment of the intracavernosal injection platelet‐rich plasma in addition to daily oral tadalafil intake in diabetic patients with erectile dysfunction non‐responding to on‐demand oral PDE5 inhibitors. Andrologia 54:6.
Crossref
Paul Williams, Hayley McBain, Aliya Amirova, Stanton Newman & Kathleen Mulligan. (2020) Men’s beliefs about treatment for erectile dysfunction—what influences treatment use? A systematic review. International Journal of Impotence Research 33:1, pages 16-42.
Crossref
E. Baydaroglu, P. Eschwège, J. Hubert & R. El Osta. (2019) Les génériques d’inhibiteur de la 5 phosphodiestérase améliorent-ils l’observance au traitement en raison d’un coût moindre ?. Progrès en Urologie 29:6, pages 326-331.
Crossref
Taymour Mostafa, Laila A. Rashed, Dina A. Sabry, Ihab Osman, Nashaat Nabil, Firas Kareem & Ingi A. Mostafa. (2018) Serum l-carnitine and vitamin D levels may be low among oral sildenafil citrate non-responders. International Journal of Impotence Research 31:2, pages 85-91.
Crossref
Binbin Gong, Ming Ma, Wenjie Xie, Xiaorong Yang, Yongming Huang, Ting Sun, Yanping Luo & Jiao Huang. (2017) Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis. International Urology and Nephrology 49:10, pages 1731-1740.
Crossref
Taymour Mostafa. (2017) Non-Sexual Implications of Phosphodiesterase Type 5 Inhibitors. Sexual Medicine Reviews 5:2, pages 170-199.
Crossref
G. Corona, G. Rastrelli, A. Burri, E. Serra, D. Gianfrilli, E. Mannucci, E. A. Jannini & M. Maggi. (2016) First-generation phosphodiesterase type 5 inhibitors dropout: a comprehensive review and meta-analysis. Andrology 4:6, pages 1002-1009.
Crossref
Taymour Mostafa. (2016) Useful Implications of Low-dose Long-term Use of PDE-5 Inhibitors. Sexual Medicine Reviews 4:3, pages 270-284.
Crossref
J. Buvat, D. Hatzichristou, F. G. Boess, H. Büttner, N. Gehchan, C. Henneges & H. Porst. (2014) Continuation and effectiveness of tadalafil once daily during a 6‐month observational study in erectile dysfunction: the EDATE study . International Journal of Clinical Practice 68:9, pages 1087-1099.
Crossref
M. G. Kirby, I. D. White, J. Butcher, B. Challacombe, J. Coe, L. Grover, P. Hegarty, G. Jackson, A. Lowndes, H. Payne, J. Rees, V. Sangar & A. Thompson. (2013) Development of UK recommendations on treatment for post‐surgical erectile dysfunction . International Journal of Clinical Practice 68:5, pages 590-608.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.